Origin Pharma

Global manufacturer of pharmaceutical packaging expands its facilities in the fight against the Covid-19 pandemic.


 Share via LinkedIn  Share via Twitter  Share via Facebook  Share via email

Read time: 4 mins      Added: 30/11/2021

Family-owned business, Origin Pharma Packaging specialises in producing medicine bottles for liquids and tablets and is a leading supplier to UK pharmacists.

After investing £12 million in new facilities Origin has been producing millions of components used in Covid-19 PCR tests.

The Hull-based business, which also has offices in Glasgow, Manchester, London and Sydney, relocated its distribution depot to a new site in Scunthorpe and redeveloped the vacated space at its headquarters to create a new facility for filling the vials used in sample collection kits. The facility, which is highly automated and completely sterile, can fill up to 140 million vials per year.

The investment will also help develop a new line of interactive packaging that will help record data in clinical trials of new drugs, making the process faster and more accurate.

Managing director, Keith Wade said, “Demand for sample collection kits meant that we had to flex very quickly and get this facility up and running within months. It is one of the leading facilities of its kind in the country and is a big asset for the business.

“We felt obliged to be part of the fight against the pandemic, both at home and around the world.

“It’s a versatile site, opening up new opportunities for us to work alongside new partners, and creating highly-skilled jobs. We’ve never stopped investing, but this will take us to the next level.”

The investment from Lloyds Bank will help Origin achieve its ambition to double turnover within three years. Around 30% of revenues currently come from exports, and the company is pursuing growth opportunities in Europe, including in the medicinal cannabis sector and cosmetics industry.

Natalie Hancock, relationship director at Lloyds Bank, said, “Origin has risen to the challenge of the coronavirus pandemic and is an essential supplier of tests to countries around the world.

“This investment means that, as well as designing and manufacturing pharmaceutical packaging to the highest standards, by branching out into component production Origin can now provide a complete solution for its customers.

“Origin is a fantastic example of an innovative, entrepreneurial and highly ambitious Yorkshire business that is making a difference in the world as well as achieving commercial success.”

Orgin Pharma


Sustainable supply chains

Due to Covid-19 many businesses are trying to make their supply chains more resilient, but why not make them greener and more sustainable at the same time?

Manufacturing Industry Experience

Assisting with cash flow needs, financing growth to build new supply chains, improving efficiency, or helping to penetrate new markets, we can help.

Business Loans

Whether you’re looking to expand, invest in new equipment, or borrow to manage your cash flow - our Business Loans can help you thrive.

Important legal information

Lloyds Bank is a trading name of Lloyds Bank plc, Bank of Scotland plc, Lloyds Bank Corporate Markets plc and Lloyds Bank Corporate Markets Wertpapierhandelsbank GmbH.

Lloyds Bank plc. Registered Office: 25 Gresham Street, London EC2V 7HN. Registered in England and Wales no. 2065. Bank of Scotland plc. Registered Office: The Mound, Edinburgh EH1 1YZ. Registered in Scotland no. SC327000. Lloyds Bank Corporate Markets plc. Registered office 25 Gresham Street, London EC2V 7HN. Registered in England and Wales no. 10399850. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority under registration number 119278, 169628 and 763256 respectively.

Lloyds Bank Corporate Markets Wertpapierhandelsbank GmbH is a wholly-owned subsidiary of Lloyds Bank Corporate Markets plc. Lloyds Bank Corporate Markets Wertpapierhandelsbank GmbH has its registered office at Thurn-und-Taxis Platz 6, 60313 Frankfurt, Germany. The company is registered with the Amtsgericht Frankfurt am Main, HRB 111650. Lloyds Bank Corporate Markets Wertpapierhandelsbank GmbH is supervised by the Bundesanstalt für Finanzdienstleistungsaufsicht.

Eligible deposits with us are protected by the Financial Services Compensation Scheme (FSCS). We are covered by the Financial Ombudsman Service (FOS). Please note that due to FSCS and FOS eligibility criteria not all business customers will be covered.

While all reasonable care has been taken to ensure that the information provided is correct, no liability is accepted by Lloyds Bank for any loss or damage caused to any person relying on any statement or omission. This is for information only and should not be relied upon as offering advice for any set of circumstances. Specific advice should always be sought in each instance.